BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3091656)

  • 1. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature.
    Grob JJ; Bonerandi JJ
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):211-9. PubMed ID: 3091656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical manifestations associated with the presence of lupus anticoagulant].
    Miori L; Bellosta M; Miori E; Rabbiosi G
    G Ital Dermatol Venereol; 1989 Mar; 124(3):107-10. PubMed ID: 2509330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.
    Asherson RA; Mackay IR; Harris EN
    Br Heart J; 1986 Aug; 56(2):190-3. PubMed ID: 3089242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant--the Sneddon syndrome. Report of 10 cases.
    Alegre VA; Winkelmann RK; Gastineau DA
    Int J Dermatol; 1990; 29(1):45-9. PubMed ID: 2109736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and lupus anticoagulant.
    Jindal BK; Martin MF; Gayner A
    Ann Rheum Dis; 1983 Jun; 42(3):347-9. PubMed ID: 6407406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiple clinical aspects of lupus.
    Godeau P; Piette JC; Francès C; Lê Thi Huong Du; Blétry O; Wechsler B
    Clin Exp Rheumatol; 1990; 8 Suppl 5():27-35. PubMed ID: 2123136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies: an elderly statesman Dons new garments.
    Harris EN; Hughes GR; Gharavi AE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():208-13. PubMed ID: 3112376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant and the skin. A longterm follow-up study of SLE patients with special reference to histopathological findings.
    Stephansson EA; Niemi KM; Jouhikainen T; Vaarala O; Palosuo T
    Acta Derm Venereol; 1991; 71(5):416-22. PubMed ID: 1684471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.
    Asherson RA; Khamashta MA; Gil A; Vazquez JJ; Chan O; Baguley E; Hughes GR
    Am J Med; 1989 Apr; 86(4):391-9. PubMed ID: 2494884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant.
    Alegre VA; Winkelmann RK
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):117-24. PubMed ID: 3136194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin lesions associated with circulating lupus anticoagulant.
    Alegre VA; Gastineau DA; Winkelmann RK
    Br J Dermatol; 1989 Mar; 120(3):419-29. PubMed ID: 2496741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal loss treatment in patients with antiphospholipid antibodies.
    Ordi J; Barquinero J; Vilardell M; Jordana R; Tolosa C; Selva A; Genover E
    Ann Rheum Dis; 1989 Oct; 48(10):798-802. PubMed ID: 2510616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic and hemorrhagic complications in children with the lupus anticoagulant.
    Bernstein ML; Salusinsky-Sternbach M; Bellefleur M; Esseltine DW
    Am J Dis Child; 1984 Dec; 138(12):1132-5. PubMed ID: 6439032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.
    Boey ML; Colaco CB; Gharavi AE; Elkon KB; Loizou S; Hughes GR
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1021-3. PubMed ID: 6412932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations].
    Zerbino DD; Lukasevich LL; Bilynskaia OA
    Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
    Love PE; Santoro SA
    Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic skin disease as a marker of the anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity.
    Grob JJ; Bonerandi JJ
    J Am Acad Dermatol; 1989 Jun; 20(6):1063-9. PubMed ID: 2502566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations.
    Pauzner R; Rosner E; Many A
    Acta Haematol; 1986; 76(2-3):90-4. PubMed ID: 3101369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma-gangraenosum-like ulcers associated with lupus anticoagulant.
    Selva A; Ordi J; Roca M; Huguet P; Castells-Rodellas A; Vilardell M
    Dermatology; 1994; 189(2):182-4. PubMed ID: 8075451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.